Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/EVOKE PHARMA INC/ SCHEDULE 13D/A

SEC Filing · SCHEDULE 13D/A

EVOKE PHARMA INC

SEC Filing

Filed Dec 19, 2025Accepted Dec 19, 2025, 11:15 AM ESTCIK 1403708Accession 0001104659-25-123157
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
EVOKNASDAQ · EQUITY · Historical · closed Dec 16, 2025

Recent company filings

  1. 15-12G filingDec 30, 2025
  2. EFFECT filingDec 18, 2025
  3. EFFECT filingDec 18, 2025
  4. EFFECT filingDec 18, 2025
  5. EFFECT filingDec 18, 2025

Document unavailable

This filing is not currently available in the archive. Read it on SEC EDGAR ↗